What is OmegaQuant?
OmegaQuant operates as a premier, CLIA-certified laboratory dedicated to the precise measurement of nutritional biomarkers, with a primary focus on omega-3 fatty acid profiles. The company provides critical diagnostic insights through its proprietary Omega-3 Index tests, serving a diverse clientele that spans individual consumers, expectant mothers, veterinary health providers, and clinical researchers. By bridging the gap between complex biochemical analysis and actionable health data, OmegaQuant has established itself as a vital infrastructure partner for healthcare professionals seeking to optimize patient outcomes through evidence-based nutritional interventions. Their commitment to rigorous scientific standards and collaborative research initiatives positions them as a leader in the burgeoning field of personalized preventative medicine.
How much funding has OmegaQuant raised?
OmegaQuant has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in OmegaQuant
PPP
Public-Private Partnership
What's next for OmegaQuant?
With the infusion of this recent capital, OmegaQuant is strategically positioned to scale its laboratory infrastructure and expand its reach within the global health and wellness ecosystem. The company is expected to prioritize the development of new diagnostic assays and deepen its integration with institutional research partners to further validate the clinical utility of omega-3 monitoring. As the demand for data-driven health insights continues to rise, OmegaQuant's focus on high-fidelity nutritional analytics will likely serve as a catalyst for sustained growth and market penetration. Future initiatives will likely center on enhancing digital health platforms to provide seamless reporting for both practitioners and end-users, ensuring that the company remains at the forefront of the nutritional diagnostics industry.
See full OmegaQuant company page
